checkpointinhibitort
Checkpoint inhibitors are a type of immunotherapy used in cancer treatment. They work by targeting specific proteins that act as "brakes" on the immune system, allowing it to recognize and attack cancer cells more effectively. Normally, these checkpoints prevent the immune system from attacking healthy cells, but cancer cells can exploit these checkpoints to evade detection and destruction.
The primary checkpoints targeted by these drugs are CTLA-4 and PD-1/PD-L1. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
Checkpoint inhibitors are monoclonal antibodies designed to block these interactions. By blocking CTLA-4, these drugs can
These therapies have shown significant success in treating various cancers, including melanoma, lung cancer, kidney cancer,